Literature DB >> 16572202

t(5;12)(q23-31;p13) with ETV6-ACSL6 gene fusion in polycythemia vera.

A Murati, J Adélaïde, V Gelsi-Boyer, A Etienne, V Rémy, H Fezoui, D Sainty, L Xerri, N Vey, S Olschwang, D Birnbaum, M Chaffanet, M J Mozziconacci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16572202     DOI： 10.1038/sj.leu.2404194

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  6 in total

1.  A Novel IL3-ETV6 Fusion in Chronic Eosinophilic Leukemia Not Otherwise Specified With t(5; 12) (q31; p13): A Case Report and Literature Review.

Authors:  Cenzhu Zhao; Man Wang; Yuchen Zhan; Yang Xu; Suning Chen; Qinrong Wang; Jingnan An; Tianhui Liu
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

2.  Chronic eosinophilic leukemia, NOS with t(5;12)(q31;p13)/ETV6-ACSL6 gene fusion: a novel variant of myeloid proliferative neoplasm with eosinophilia.

Authors:  Ruijun Jeanna Su; Brian A Jonas; Jeanna Welborn; Jeffrey Paul Gregg; Mingyi Chen
Journal:  Hum Pathol (N Y)       Date:  2016-09

3.  Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis.

Authors:  Philipp Erben; Darko Gosenca; Martin C Müller; Jelena Reinhard; Joannah Score; Francesco Del Valle; Christoph Walz; Jürgen Mix; Georgia Metzgeroth; Thomas Ernst; Claudia Haferlach; Nicholas C P Cross; Andreas Hochhaus; Andreas Reiter
Journal:  Haematologica       Date:  2010-01-27       Impact factor: 9.941

4.  Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature.

Authors:  Javier De Luca-Johnson; Jose I Ruades Ninfea; Lauren Pearson; Joanna Conant; Ronald Bryant; Neil A Zakai; Mary E Tang
Journal:  Case Rep Med       Date:  2016-09-26

5.  ETV6-ACSL6 fusion gene in myeloid neoplasms: clinical spectrum, current practice, and outcomes.

Authors:  Xia Wu; Hao Cai; Yu Qiu; Jian Li; Dao-Bin Zhou; Xin-Xin Cao
Journal:  Orphanet J Rare Dis       Date:  2020-07-28       Impact factor: 4.123

6.  Tumor suppressor microRNAs are downregulated in myelodysplastic syndrome with spliceosome mutations.

Authors:  Derya Aslan; Christian Garde; Mette Katrine Nygaard; Alexandra Søgaard Helbo; Konstantinos Dimopoulos; Jakob Werner Hansen; Marianne Tang Severinsen; Marianne Bach Treppendahl; Lene Dissing Sjø; Kirsten Grønbæk; Lasse Sommer Kristensen
Journal:  Oncotarget       Date:  2016-03-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.